TY - JOUR T1 - Acute effects of supplemental oxygen therapy using different nasal cannulas on walking capacity in patients with idiopathic pulmonary fibrosis: a randomised crossover trial JF - ERJ Open Research JO - erjor DO - 10.1183/23120541.00197-2020 VL - 6 IS - 3 SP - 00197-2020 AU - Tessa Schneeberger AU - Daniela Leitl AU - Rainer Gloeckl AU - Inga Jarosch AU - Daniela Reimann AU - Wolfgang Hitzl AU - Rembert Koczulla AU - Klaus Kenn Y1 - 2020/07/01 UR - http://openres.ersjournals.com/content/6/3/00197-2020.abstract N2 - Patients with idiopathic pulmonary fibrosis (IPF) and concurrent hypoxaemia should be treated with oxygen therapy [1]. Oxygen therapy is commonly given by conventional nasal cannulas (CNC), but can also be delivered by other less conventional cannulas such as the Oxymizer. The Oxymizer is a nasal cannula with an internal pendant reservoir incorporated in the lumen at the patient end which has the potential to provide increased oxygenation while using the same oxygen setting as one would with CNC [2].Something simple, like changing a nasal cannula for a technologically superior one, can improve exercise capacity and oxygenation in patients with IPF. There is a need to develop improved cannulas for comfort and patient acceptance. https://bit.ly/2NelacEWe thank Clancy J. Dennis for the linguistic review of this manuscript. ER -